Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Wilde

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pathology|June 1, 1988
Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitisJ T Wilde, W E Thomas, D A Lane, et al.
British Journal of Haematology|August 25, 1999
A novel ELISA-based primer extension assay for the detection of the factor V Leiden mutationJ T Wilde, J J O'Sullivan, J L Roper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand diseaseH G Watson, J T Wilde, G Dolan, et al.
Thrombosis and Haemostasis|November 19, 1997
Another variant pattern of intron 22 inversion in the factor VIII gene seen in a severe haemophilia A patientM S Enayat, B D Theophilus, M D Williams, et al.
British Journal of Haematology|December 31, 1997
Hepatitis G virus infection in patients with bleeding disordersJ T Wilde, M M Ahmed, K E Collingham, et al.
British Journal of Haematology|December 3, 1999
Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disordersJ T Wilde, C A Lee, P Collins, et al.
British Journal of Haematology|February 26, 2000
Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disordersP L Shields, D J Mutimer, D Muir, et al.
British Journal of Haematology|April 1, 1990
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigenM D Boisclair, D A Lane, J T Wilde, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2011
UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011J T Wilde, D Mutimer, G Dolan, et al.
British Journal of Haematology|June 1, 1988
Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis timeJ G Wright, P Cooper, B Astedt, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|June 1, 1988
Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitisJ T Wilde, W E Thomas, D A Lane, et al.
British Journal of Haematology|August 25, 1999
A novel ELISA-based primer extension assay for the detection of the factor V Leiden mutationJ T Wilde, J J O'Sullivan, J L Roper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand diseaseH G Watson, J T Wilde, G Dolan, et al.
Thrombosis and Haemostasis|November 19, 1997
Another variant pattern of intron 22 inversion in the factor VIII gene seen in a severe haemophilia A patientM S Enayat, B D Theophilus, M D Williams, et al.
British Journal of Haematology|December 31, 1997
Hepatitis G virus infection in patients with bleeding disordersJ T Wilde, M M Ahmed, K E Collingham, et al.
British Journal of Haematology|December 3, 1999
Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disordersJ T Wilde, C A Lee, P Collins, et al.
British Journal of Haematology|February 26, 2000
Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disordersP L Shields, D J Mutimer, D Muir, et al.
British Journal of Haematology|April 1, 1990
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigenM D Boisclair, D A Lane, J T Wilde, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2011
UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011J T Wilde, D Mutimer, G Dolan, et al.
British Journal of Haematology|June 1, 1988
Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis timeJ G Wright, P Cooper, B Astedt, et al.
Pageof 5